Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species

Xiangcheng Qing1, Zengwu Shao1, Xiao Lv1

  • 1Departments of Orthopedics.

Anti-Cancer Drugs
|February 9, 2018
PubMed

Insights

MTH1 (mut Tpase 1) is highly expressed in osteosarcoma (OS). Targeting MTH1 with (S)-crizotinib inhibits OS cell proliferation and migration by activating reactive oxygen species (ROS).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • MTH1 (mut Tpase 1) is a key target in cancer therapy, particularly for 'cancer phenotypic lethality'.
  • Osteosarcoma (OS) is a common bone cancer with limited treatment options, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the anticancer effects of the MTH1-targeted drug (S)-crizotinib on osteosarcoma (OS) cells.
  • To explore the role of MTH1 expression in OS development and its potential as a therapeutic target.

Main Methods:

  • Immunohistochemistry and western blot to detect MTH1 expression in OS tissues and cells.
  • siRNA technology and CCK8 assays to assess MTH1's effect on OS cell viability.
  • In-vitro assays to evaluate (S)-crizotinib's efficacy, including apoptosis, cell cycle arrest, and migration.
  • Detection of intracellular 8-oxo-dGTP levels and reactive oxygen species (ROS) using specific staining methods.

Main Results:

  • MTH1 expression was significantly elevated in OS tissues and cell lines compared to normal controls.
  • Knockdown of MTH1 using siRNA suppressed OS cell proliferation.
  • (S)-Crizotinib inhibited OS cell proliferation, induced apoptosis, caused G0/G1 cell cycle arrest, and suppressed migration.
  • The anticancer effects of (S)-crizotinib were mediated by targeting MTH1 and activating ROS.

Conclusions:

  • MTH1 is a promising therapeutic target for osteosarcoma.
  • (S)-Crizotinib demonstrates significant anticancer potential against OS by modulating MTH1 and ROS.
  • This study provides a strong theoretical basis for the clinical application of (S)-crizotinib in treating osteosarcoma.

Related Concept Videos

What is a Species?01:17

What is a Species?

Overview
50.6K
Formation of Species01:31

Formation of Species

Speciation describes the formation of one or more new species from one or sometimes multiple original species. The resulting species are discrete from the parent species, and barriers to reproduction will typically exist. There are two primary mechanisms, speciation with and without geographic isolation—allopatric and sympatric speciation, respectively.
45.5K
Keystone Species01:39

Keystone Species

Measures of species biodiversity, such as richness (i.e., the number of species present) and evenness (i.e., their relative abundance), describe an ecological community’s structure. Many factors affect community structure, including abiotic factors (e.g., sunlight and nutrients), disturbances (e.g., fire or flood), species interactions (e.g., predation or competition), and chance events (e.g., foreign species invasion). Certain species—such as keystone species—also play a...
25.1K
Cross-reactivity00:42

Cross-reactivity

Overview
33.2K
Reactivity of Enols01:18

Reactivity of Enols

Enols are a class of compounds where a hydroxyl group is attached to a carbon–carbon double bond, which implies that it is a vinyl alcohol. A carbonyl compound with an α hydrogen undergoes keto–enol tautomerism and remains in equilibrium with its tautomer, the enol form. Usually, the keto tautomer is present in a higher concentration than the enol tautomer due to the higher bond energy of C=O compared to C=C. Moreover, the direction of the keto–enol equilibrium is...
4.2K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K